explore
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
Next article: At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
hotspot
explore
-
Diversifying clinical trials isn't enough to close racial gaps: study
2025-09-27 12:58 -
Federal weight loss drug coverage is 30 years out of date
2025-09-27 12:02 -
Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi
2025-09-27 12:00 -
CDC recommends rationing of RSV shot due to shortages
2025-09-27 11:46 -
Goldman Sachs launches $650M fund for life science investments
2025-09-27 11:46 -
UCB departs biotech trade group BIO
2025-09-27 11:29